APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Disease Prediction Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI Disease Prediction Software Market Outlook and Growth Opportunities 2026

5 January 2026204 pages

Choose your research edition.

Industry ResearchAI Disease Prediction Software Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Disease Prediction Software Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal AI Disease Prediction Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Disease Prediction Software Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Disease Prediction Software Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global AI Disease Prediction Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Disease Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Disease Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Disease Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Disease Prediction Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Disease Prediction Software market include IntelliGenes, IBM Watson Oncology, PathAI, Zebra Medical Vision, Siemens Healthineers, GitHub LifeAI, DeepView, Google DeepMind and Binariks, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Disease Prediction Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Disease Prediction Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Disease Prediction Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Disease Prediction Software market.

AI Disease Prediction Software Segment by Company

IntelliGenes

IBM Watson Oncology

PathAI

Zebra Medical Vision

Siemens Healthineers

GitHub LifeAI

DeepView

Google DeepMind

Binariks

Paige.AI

Lunit INSIGHT

Arterys

Winterlight Labs

BrainScope

Livongo

Deep Genomics

IDx-DR

ChestEye

Viz.ai

AI Disease Prediction Software Segment by Type

Cloud-based

On-premises

AI Disease Prediction Software Segment by Application

Cancer

Cardiovascular Disease

Nervous System Disease

Chronic Disease and Metabolic Disease

Others

AI Disease Prediction Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Disease Prediction Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Disease Prediction Software key companies, revenue, market share, and recent developments.

3. To split the AI Disease Prediction Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Disease Prediction Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Disease Prediction Software significant trends, drivers, influence factors in global and regions.

6. To analyze AI Disease Prediction Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Disease Prediction Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Disease Prediction Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Disease Prediction Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Disease Prediction Software industry.

Chapter 3: Detailed analysis of AI Disease Prediction Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Disease Prediction Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Disease Prediction Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Disease Prediction Software Industry Trends Table 2. AI Disease Prediction Software Industry Drivers Table 3. AI Disease Prediction Software Industry Opportunities and Challenges Table 4. AI Disease Prediction Software Industry Restraints Table 5. Global AI Disease Prediction Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Disease Prediction Software Revenue Share by Company (2021-2026) Table 7. Global AI Disease Prediction Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Disease Prediction Software Key Company Manufacturing Base & Headquarters Table 9. Global AI Disease Prediction Software Company, Product Type & Application Table 10. Global AI Disease Prediction Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Disease Prediction Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-based Table 15. Significant Companies of On-premises Table 16. Global AI Disease Prediction Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global AI Disease Prediction Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global AI Disease Prediction Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global AI Disease Prediction Software Sales Value Share by Type (2021-2026) Table 20. Global AI Disease Prediction Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Cancer Table 22. Significant Companies of Cardiovascular Disease Table 23. Significant Companies of Nervous System Disease Table 24. Significant Companies of Chronic Disease and Metabolic Disease Table 25. Significant Companies of Others Table 26. Global AI Disease Prediction Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global AI Disease Prediction Software Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global AI Disease Prediction Software Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global AI Disease Prediction Software Sales Value Share by Application (2021-2026) Table 30. Global AI Disease Prediction Software Sales Value Share by Application (2027-2032) Table 31. Global AI Disease Prediction Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AI Disease Prediction Software Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global AI Disease Prediction Software Sales Value Share by Region (2021-2026) Table 34. Global AI Disease Prediction Software Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global AI Disease Prediction Software Sales Value Share by Region (2027-2032) Table 36. Global AI Disease Prediction Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global AI Disease Prediction Software Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global AI Disease Prediction Software Sales Value Market Share by Country (2021-2026) Table 39. Global AI Disease Prediction Software Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global AI Disease Prediction Software Sales Value Market Share by Country (2027-2032) Table 41. IntelliGenes Company Information Table 42. IntelliGenes Business Overview Table 43. IntelliGenes AI Disease Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. IntelliGenes AI Disease Prediction Software Product Portfolio Table 45. IntelliGenes Recent Development Table 46. IBM Watson Oncology Company Information Table 47. IBM Watson Oncology Business Overview Table 48. IBM Watson Oncology AI Disease Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. IBM Watson Oncology AI Disease Prediction Software Product Portfolio Table 50. IBM Watson Oncology Recent Development Table 51. PathAI Company Information Table 52. PathAI Business Overview Table 53. PathAI AI Disease Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. PathAI AI Disease Prediction Software Product Portfolio Table 55. PathAI Recent Development Table 56. Zebra Medical Vision Company Information Table 57. Zebra Medical Vision Business Overview Table 58. Zebra Medical Vision AI Disease Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Zebra Medical Vision AI Disease Prediction Software Product Portfolio Table 60. Zebra Medical Vision Recent Development Table 61. Siemens Healthineers Company Information Table 62. Siemens Healthineers Business Overview Table 63. Siemens Healthineers AI Disease Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Siemens Healthineers AI Disease Prediction Software Product Portfolio Table 65. Siemens Healthineers Recent Development Table 66. GitHub LifeAI Company Information Table 67. GitHub LifeAI Business Overview Table 68. GitHub LifeAI AI Disease Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. GitHub LifeAI AI Disease Prediction Software Product Portfolio Table 70. GitHub LifeAI Recent Development Table 71. DeepView Company Information Table 72. DeepView Business Overview Table 73. DeepView AI Disease Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. DeepView AI Disease Prediction Software Product Portfolio Table 75. DeepView Recent Development Table 76. Google DeepMind Company Information Table 77. Google DeepMind Business Overview Table 78. Google DeepMind AI Disease Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Google DeepMind AI Disease Prediction Software Product Portfolio Table 80. Google DeepMind Recent Development Table 81. Binariks Company Information Table 82. Binariks Business Overview Table 83. Binariks AI Disease Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Binariks AI Disease Prediction Software Product Portfolio Table 85. Binariks Recent Development Table 86. Paige.AI Company Information Table 87. Paige.AI Business Overview Table 88. Paige.AI AI Disease Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Paige.AI AI Disease Prediction Software Product Portfolio Table 90. Paige.AI Recent Development Table 91. Lunit INSIGHT Company Information Table 92. Lunit INSIGHT Business Overview Table 93. Lunit INSIGHT AI Disease Prediction Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Lunit INSIGHT AI Disease Prediction Software Product Portfolio Table 95. Lunit INSIGHT Recent Development Table 96. Arterys Company Information Table 97. Arterys Business Overview Table 98. Arterys AI Disease Prediction Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Arterys AI Disease Prediction Software Product Portfolio Table 100. Arterys Recent Development Table 101. Winterlight Labs Company Information Table 102. Winterlight Labs Business Overview Table 103. Winterlight Labs AI Disease Prediction Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Winterlight Labs AI Disease Prediction Software Product Portfolio Table 105. Winterlight Labs Recent Development Table 106. BrainScope Company Information Table 107. BrainScope Business Overview Table 108. BrainScope AI Disease Prediction Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. BrainScope AI Disease Prediction Software Product Portfolio Table 110. BrainScope Recent Development Table 111. Livongo Company Information Table 112. Livongo Business Overview Table 113. Livongo AI Disease Prediction Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Livongo AI Disease Prediction Software Product Portfolio Table 115. Livongo Recent Development Table 116. Deep Genomics Company Information Table 117. Deep Genomics Business Overview Table 118. Deep Genomics AI Disease Prediction Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Deep Genomics AI Disease Prediction Software Product Portfolio Table 120. Deep Genomics Recent Development Table 121. IDx-DR Company Information Table 122. IDx-DR Business Overview Table 123. IDx-DR AI Disease Prediction Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. IDx-DR AI Disease Prediction Software Product Portfolio Table 125. IDx-DR Recent Development Table 126. ChestEye Company Information Table 127. ChestEye Business Overview Table 128. ChestEye AI Disease Prediction Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. ChestEye AI Disease Prediction Software Product Portfolio Table 130. ChestEye Recent Development Table 131. Viz.ai Company Information Table 132. Viz.ai Business Overview Table 133. Viz.ai AI Disease Prediction Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Viz.ai AI Disease Prediction Software Product Portfolio Table 135. Viz.ai Recent Development Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. AI Disease Prediction Software Product Image Figure 2. Global AI Disease Prediction Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Disease Prediction Software Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Disease Prediction Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-based Image Figure 8. On-premises Image Figure 9. Global AI Disease Prediction Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global AI Disease Prediction Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global AI Disease Prediction Software Sales Value Share by Type (2021-2032) Figure 12. Cancer Image Figure 13. Cardiovascular Disease Image Figure 14. Nervous System Disease Image Figure 15. Chronic Disease and Metabolic Disease Image Figure 16. Others Image Figure 17. Global AI Disease Prediction Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global AI Disease Prediction Software Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global AI Disease Prediction Software Sales Value Share by Application (2021-2032) Figure 20. Global AI Disease Prediction Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global AI Disease Prediction Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America AI Disease Prediction Software Sales Value (2021-2032) & (US$ Million) Figure 23. North America AI Disease Prediction Software Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe AI Disease Prediction Software Sales Value (2021-2032) & (US$ Million) Figure 25. Europe AI Disease Prediction Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific AI Disease Prediction Software Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific AI Disease Prediction Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America AI Disease Prediction Software Sales Value (2021-2032) & (US$ Million) Figure 29. South America AI Disease Prediction Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa AI Disease Prediction Software Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa AI Disease Prediction Software Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt AI Disease Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-premises
Applications
  • Cancer
  • Cardiovascular Disease
  • Nervous System Disease
  • Chronic Disease and Metabolic Disease
  • Others
Companies covered
  • IntelliGenes
  • IBM Watson Oncology
  • PathAI
  • Zebra Medical Vision
  • Siemens Healthineers
  • GitHub LifeAI
  • DeepView
  • Google DeepMind
  • Binariks
  • Paige.AI
  • Lunit INSIGHT
  • Arterys
  • Winterlight Labs
  • BrainScope
  • Livongo
  • Deep Genomics
  • IDx-DR
  • ChestEye
  • Viz.ai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Disease Prediction Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Disease Prediction Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Disease Prediction Software Market Dynamics
  1. 2.1 AI Disease Prediction Software Industry Trends
  2. 2.2 AI Disease Prediction Software Industry Drivers
  3. 2.3 AI Disease Prediction Software Industry Opportunities and Challenges
  4. 2.4 AI Disease Prediction Software Industry Restraints
3 AI Disease Prediction Software Market by Company
  1. 3.1 Global AI Disease Prediction Software Company Revenue Ranking in 2025
  2. 3.2 Global AI Disease Prediction Software Revenue by Company (2021-2026)
  3. 3.3 Global AI Disease Prediction Software Company Ranking (2024-2026)
  4. 3.4 Global AI Disease Prediction Software Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Disease Prediction Software Company Product Type and Application
  6. 3.6 Global AI Disease Prediction Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Disease Prediction Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Disease Prediction Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Disease Prediction Software Market by Type
  1. 4.1 AI Disease Prediction Software Type Introduction
  2. 4.1.1 Cloud-based
  3. 4.1.2 On-premises
  4. 4.2 Global AI Disease Prediction Software Sales Value by Type
  5. 4.2.1 Global AI Disease Prediction Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global AI Disease Prediction Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global AI Disease Prediction Software Sales Value Share by Type (2021-2032)
5 AI Disease Prediction Software Market by Application
  1. 5.1 AI Disease Prediction Software Application Introduction
  2. 5.1.1 Cancer
  3. 5.1.2 Cardiovascular Disease
  4. 5.1.3 Nervous System Disease
  5. 5.1.4 Chronic Disease and Metabolic Disease
  6. 5.1.5 Others
  7. 5.2 Global AI Disease Prediction Software Sales Value by Application
  8. 5.2.1 Global AI Disease Prediction Software Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global AI Disease Prediction Software Sales Value by Application (2021-2032)
  10. 5.2.3 Global AI Disease Prediction Software Sales Value Share by Application (2021-2032)
6 AI Disease Prediction Software Regional Value Analysis
  1. 6.1 Global AI Disease Prediction Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Disease Prediction Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Disease Prediction Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Disease Prediction Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Disease Prediction Software Sales Value (2021-2032)
  7. 6.3.2 North America AI Disease Prediction Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Disease Prediction Software Sales Value (2021-2032)
  10. 6.4.2 Europe AI Disease Prediction Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Disease Prediction Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Disease Prediction Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Disease Prediction Software Sales Value (2021-2032)
  16. 6.6.2 South America AI Disease Prediction Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Disease Prediction Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Disease Prediction Software Sales Value Share by Country, 2025 VS 2032
7 AI Disease Prediction Software Country-level Value Analysis
  1. 7.1 Global AI Disease Prediction Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Disease Prediction Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Disease Prediction Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Disease Prediction Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Disease Prediction Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Disease Prediction Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Disease Prediction Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 IntelliGenes
  2. 8.1.1 IntelliGenes Company Information
  3. 8.1.2 IntelliGenes Business Overview
  4. 8.1.3 IntelliGenes AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 IntelliGenes AI Disease Prediction Software Product Portfolio
  6. 8.1.5 IntelliGenes Recent Developments
  7. 8.2 IBM Watson Oncology
  8. 8.2.1 IBM Watson Oncology Company Information
  9. 8.2.2 IBM Watson Oncology Business Overview
  10. 8.2.3 IBM Watson Oncology AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 IBM Watson Oncology AI Disease Prediction Software Product Portfolio
  12. 8.2.5 IBM Watson Oncology Recent Developments
  13. 8.3 PathAI
  14. 8.3.1 PathAI Company Information
  15. 8.3.2 PathAI Business Overview
  16. 8.3.3 PathAI AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 PathAI AI Disease Prediction Software Product Portfolio
  18. 8.3.5 PathAI Recent Developments
  19. 8.4 Zebra Medical Vision
  20. 8.4.1 Zebra Medical Vision Company Information
  21. 8.4.2 Zebra Medical Vision Business Overview
  22. 8.4.3 Zebra Medical Vision AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zebra Medical Vision AI Disease Prediction Software Product Portfolio
  24. 8.4.5 Zebra Medical Vision Recent Developments
  25. 8.5 Siemens Healthineers
  26. 8.5.1 Siemens Healthineers Company Information
  27. 8.5.2 Siemens Healthineers Business Overview
  28. 8.5.3 Siemens Healthineers AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Siemens Healthineers AI Disease Prediction Software Product Portfolio
  30. 8.5.5 Siemens Healthineers Recent Developments
  31. 8.6 GitHub LifeAI
  32. 8.6.1 GitHub LifeAI Company Information
  33. 8.6.2 GitHub LifeAI Business Overview
  34. 8.6.3 GitHub LifeAI AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GitHub LifeAI AI Disease Prediction Software Product Portfolio
  36. 8.6.5 GitHub LifeAI Recent Developments
  37. 8.7 DeepView
  38. 8.7.1 DeepView Company Information
  39. 8.7.2 DeepView Business Overview
  40. 8.7.3 DeepView AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 DeepView AI Disease Prediction Software Product Portfolio
  42. 8.7.5 DeepView Recent Developments
  43. 8.8 Google DeepMind
  44. 8.8.1 Google DeepMind Company Information
  45. 8.8.2 Google DeepMind Business Overview
  46. 8.8.3 Google DeepMind AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Google DeepMind AI Disease Prediction Software Product Portfolio
  48. 8.8.5 Google DeepMind Recent Developments
  49. 8.9 Binariks
  50. 8.9.1 Binariks Company Information
  51. 8.9.2 Binariks Business Overview
  52. 8.9.3 Binariks AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Binariks AI Disease Prediction Software Product Portfolio
  54. 8.9.5 Binariks Recent Developments
  55. 8.10 Paige.AI
  56. 8.10.1 Paige.AI Company Information
  57. 8.10.2 Paige.AI Business Overview
  58. 8.10.3 Paige.AI AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Paige.AI AI Disease Prediction Software Product Portfolio
  60. 8.10.5 Paige.AI Recent Developments
  61. 8.11 Lunit INSIGHT
  62. 8.11.1 Lunit INSIGHT Company Information
  63. 8.11.2 Lunit INSIGHT Business Overview
  64. 8.11.3 Lunit INSIGHT AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lunit INSIGHT AI Disease Prediction Software Product Portfolio
  66. 8.11.5 Lunit INSIGHT Recent Developments
  67. 8.12 Arterys
  68. 8.12.1 Arterys Company Information
  69. 8.12.2 Arterys Business Overview
  70. 8.12.3 Arterys AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Arterys AI Disease Prediction Software Product Portfolio
  72. 8.12.5 Arterys Recent Developments
  73. 8.13 Winterlight Labs
  74. 8.13.1 Winterlight Labs Company Information
  75. 8.13.2 Winterlight Labs Business Overview
  76. 8.13.3 Winterlight Labs AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Winterlight Labs AI Disease Prediction Software Product Portfolio
  78. 8.13.5 Winterlight Labs Recent Developments
  79. 8.14 BrainScope
  80. 8.14.1 BrainScope Company Information
  81. 8.14.2 BrainScope Business Overview
  82. 8.14.3 BrainScope AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BrainScope AI Disease Prediction Software Product Portfolio
  84. 8.14.5 BrainScope Recent Developments
  85. 8.15 Livongo
  86. 8.15.1 Livongo Company Information
  87. 8.15.2 Livongo Business Overview
  88. 8.15.3 Livongo AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Livongo AI Disease Prediction Software Product Portfolio
  90. 8.15.5 Livongo Recent Developments
  91. 8.16 Deep Genomics
  92. 8.16.1 Deep Genomics Company Information
  93. 8.16.2 Deep Genomics Business Overview
  94. 8.16.3 Deep Genomics AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Deep Genomics AI Disease Prediction Software Product Portfolio
  96. 8.16.5 Deep Genomics Recent Developments
  97. 8.17 IDx-DR
  98. 8.17.1 IDx-DR Company Information
  99. 8.17.2 IDx-DR Business Overview
  100. 8.17.3 IDx-DR AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  101. 8.17.4 IDx-DR AI Disease Prediction Software Product Portfolio
  102. 8.17.5 IDx-DR Recent Developments
  103. 8.18 ChestEye
  104. 8.18.1 ChestEye Company Information
  105. 8.18.2 ChestEye Business Overview
  106. 8.18.3 ChestEye AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  107. 8.18.4 ChestEye AI Disease Prediction Software Product Portfolio
  108. 8.18.5 ChestEye Recent Developments
  109. 8.19 Viz.ai
  110. 8.19.1 Viz.ai Company Information
  111. 8.19.2 Viz.ai Business Overview
  112. 8.19.3 Viz.ai AI Disease Prediction Software Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Viz.ai AI Disease Prediction Software Product Portfolio
  114. 8.19.5 Viz.ai Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst